Free Trial

Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

Amneal Pharmaceuticals logo
$8.07 +0.32 (+4.13%)
(As of 12/17/2024 ET)

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/26/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:26 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
9:39 AM
Amneal Pharmaceuticals (Subject)
Kiely John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
1:01 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
12:49 PM
Amneal Pharmaceuticals (Subject)
Daly Jason B. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:08 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:51 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
10/30/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G
10/01/2024
6:10 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:12 PM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:27 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
2:13 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:39 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:42 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:44 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:46 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:18 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:28 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:31 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:34 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:35 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:38 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
5:03 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/14/2024
4:04 PM
Amneal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:39 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:40 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:54 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The #1 Crypto for AI (Ad)

We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”

Learn more about it by watching THIS NOW.
03/05/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:03 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:09 PM
Amneal Pharmaceuticals (Subject)
Mahesh Akram (Filed by)
Form SC 13G
01/03/2024
3:30 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
12/26/2023
6:06 PM
Amneal Pharmaceuticals (Filer)
Form CERT
12/26/2023
3:10 PM
Amneal Pharmaceuticals (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMRX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners